Immune Predictors of Mortality After Ribonucleic Acid Virus Infection
- PMID: 31621854
- PMCID: PMC7107456
- DOI: 10.1093/infdis/jiz531
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection
Abstract
Background: Virus infections result in a range of clinical outcomes for the host, from asymptomatic to severe or even lethal disease. Despite global efforts to prevent and treat virus infections to limit morbidity and mortality, the continued emergence and re-emergence of new outbreaks as well as common infections such as influenza persist as a health threat. Challenges to the prevention of severe disease after virus infection include both a paucity of protective vaccines as well as the early identification of individuals with the highest risk that may require supportive treatment.
Methods: We completed a screen of mice from the Collaborative Cross (CC) that we infected with influenza, severe acute respiratory syndrome-coronavirus, and West Nile virus.
Results: The CC mice exhibited a range of disease manifestations upon infections, and we used this natural variation to identify strains with mortality after infection and strains exhibiting no mortality. We then used comprehensive preinfection immunophenotyping to identify global baseline immune correlates of protection from mortality to virus infection.
Conclusions: These data suggest that immune phenotypes might be leveraged to identify humans at highest risk of adverse clinical outcomes upon infection, who may most benefit from intensive clinical interventions, in addition to providing insight for rational vaccine design.
Keywords: Collaborative Cross; RNA virus infection; immune correlates of mortality.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Immune Correlates of Protection From West Nile Virus Neuroinvasion and Disease.J Infect Dis. 2019 Mar 15;219(7):1162-1171. doi: 10.1093/infdis/jiy623. J Infect Dis. 2019. PMID: 30371803 Free PMC article.
-
Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.J Virol. 2011 Jan;85(1):217-30. doi: 10.1128/JVI.01805-10. Epub 2010 Oct 27. J Virol. 2011. PMID: 20980507 Free PMC article.
-
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.PLoS One. 2011 Apr 26;6(4):e18995. doi: 10.1371/journal.pone.0018995. PLoS One. 2011. PMID: 21541326 Free PMC article.
-
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.Avian Pathol. 2003 Dec;32(6):567-82. doi: 10.1080/03079450310001621198. Avian Pathol. 2003. PMID: 14676007 Free PMC article. Review.
-
Yellow fever vector live-virus vaccines: West Nile virus vaccine development.Trends Mol Med. 2001 Aug;7(8):350-4. doi: 10.1016/s1471-4914(01)02048-2. Trends Mol Med. 2001. PMID: 11516995 Free PMC article. Review.
Cited by
-
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection.bioRxiv [Preprint]. 2020 Sep 21:2020.09.21.306837. doi: 10.1101/2020.09.21.306837. bioRxiv. 2020. Update in: PLoS Pathog. 2021 Jan 29;17(1):e1009287. doi: 10.1371/journal.ppat.1009287 PMID: 32995791 Free PMC article. Updated. Preprint.
-
Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19.Res Sq [Preprint]. 2024 Jul 29:rs.3.rs-4675061. doi: 10.21203/rs.3.rs-4675061/v1. Res Sq. 2024. Update in: Sci Rep. 2024 Oct 24;14(1):25147. doi: 10.1038/s41598-024-77087-1 PMID: 39149485 Free PMC article. Updated. Preprint.
-
Peripheral and lung resident memory T cell responses against SARS-CoV-2.Nat Commun. 2021 May 21;12(1):3010. doi: 10.1038/s41467-021-23333-3. Nat Commun. 2021. PMID: 34021148 Free PMC article.
-
Forward genetic screen of homeostatic antibody levels in the Collaborative Cross identifies MBD1 as a novel regulator of B cell homeostasis.PLoS Genet. 2022 Dec 27;18(12):e1010548. doi: 10.1371/journal.pgen.1010548. eCollection 2022 Dec. PLoS Genet. 2022. PMID: 36574452 Free PMC article.
-
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.PLoS Pathog. 2021 Jan 29;17(1):e1009287. doi: 10.1371/journal.ppat.1009287. eCollection 2021 Jan. PLoS Pathog. 2021. PMID: 33513210 Free PMC article.
References
-
- Churchill GA, Airey DC, Allayee H, et al. ; Complex Trait Consortium The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004; 36:1133–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases